- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01835418
Bedtime Administration of Amlodipine Versus Lisinopril (BAVLART)
April 18, 2013 updated by: David Ingham, Allina Health System
Bedtime Administration of Amlodipine Versus Lisinopril: a Randomized Trial
This study seeks to compare the differences in effectiveness among individual patients treated at for hypertension with bedtime administration of amlodipine versus lisinopril.
There will be an analysis of whether one medication was more effective than another and whether specific patient factors could predict who responded better to which one.
Study Overview
Study Type
Interventional
Enrollment (Anticipated)
100
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age 40 to 80
- Newly diagnosed hypertension based on 24 hour ambulatory blood pressure monitor criteria.
- Minimum Asleep SBP mean of ≥ 120mmHg for inclusion.
Exclusion Criteria:
- Current antihypertensive medication use
- Baseline GFR < 45
- Preexisting macroproteinuria
- Chronic congestive heart failure
- History of CVA
- Diabetes Mellitus
- Pregnancy
- Night-shift work
- Other preexisting contraindication to amlodipine or lisinopril
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Lisinopril
bedtime administration of lisinopril 20mg
|
crossover comparison of amlodipine vs lisinopril
|
Experimental: Amlodipine
Bedtime administration of amlodipine 5mg
|
crossover comparison of amlodipine vs lisinopril
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in mean sleep-time systolic blood pressure after addition of a bedtime dose of amlodipine versus lisinopril
Time Frame: 1 year
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Changes in mean sleep-time diastolic, awake systolic and diastolic blood pressures, including comparison of % achieving target BP
Time Frame: 1 year
|
1 year
|
Impact of individual medications on sleep-time blood pressure drop (dipping status)
Time Frame: 1 year
|
1 year
|
Association of baseline renin levels to sleep-time blood pressure drop
Time Frame: 1 year
|
1 year
|
Association of baseline renin levels with response to amlodipine versus lisinopril
Time Frame: 1 year
|
1 year
|
Association of baseline dipping status with response to amlodipine versus lisinopril
Time Frame: 1 year
|
1 year
|
Association of age and response to amlodipine versus lisinopril
Time Frame: 1 year
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2013
Primary Completion (Anticipated)
July 1, 2014
Study Registration Dates
First Submitted
February 21, 2013
First Submitted That Met QC Criteria
April 18, 2013
First Posted (Estimate)
April 19, 2013
Study Record Updates
Last Update Posted (Estimate)
April 19, 2013
Last Update Submitted That Met QC Criteria
April 18, 2013
Last Verified
April 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 9529148100
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
BayerCompletedPrimary HypertensionChina
-
Addpharma Inc.Completed
-
Columbia UniversityAgency for Healthcare Research and Quality (AHRQ)Active, not recruitingWhite Coat Hypertension | Hypertension,EssentialUnited States
-
Universidade Federal de Santa MariaCompletedHealthy Volunteers | Hypertension, EssentialBrazil
-
Cytos Biotechnology AGCompletedMild Essential Hypertension | Moderate Essential HypertensionSwitzerland
-
Sulaiman AlRajhi CollegesUnknownHypertension, Essential | β-hydroxybutyrate
-
Centre Chirurgical Marie LannelongueUnknownChronic Thrombo-embolic Pulmonary Hypertension and Pulmonary Arterial HypertensionFrance
Clinical Trials on Amlodipine
-
NovartisCompleted
-
Novartis PharmaceuticalsCompletedHypertensionSweden, United States, Peru, Russian Federation, Romania, Mexico, Panama, Spain, Denmark, Italy, Greece, South Africa, Canada, Argentina, Australia, Colombia, Finland, Taiwan
-
Novartis PharmaceuticalsCompletedEssential HypertensionJapan
-
Novartis PharmaceuticalsTerminatedHypertension | Ankle EdemaNetherlands
-
Addpharma Inc.CompletedHypertension,EssentialKorea, Republic of
-
SanofiCompleted
-
Actavis Inc.Completed
-
International Bio serviceNot yet recruiting
-
Chongqing Medical UniversityUnknownComparison of Tandospirone, Amlodipine and Their Combination in Adults With Hypertension and AnxietyHypertension | AnxietyChina
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedHypertension | HypercholesterolemiaJapan